Since the approval of Enbrel® in 1998 for the treatment of rheumatoid arthritis, Fc fusion therapies have evolved into a prominent class of therapeutics; currently, several therapies are being developed for a variety of disease indications London Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list […]
Exponential increase in amount of digital data being generated, coupled to the limitations of conventional storage mediums, has created a need for sustainable storage options and DNA data storage has garnered significant interest as an alternative London Roots Analysis has announced the addition of DNA Data Storage Market, 2021-2035” report to its
Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes. Roots Analysis has announced the addition of “CD-47 Targeting Therapeutics Market, 2021-2035” report to its list of offerings. In recent years,
Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD-47 as an effective biomarker for the diagnosis and treatment purposes Roots Analysis is pleased to announce the publication of its recent study, titled, “CD-47 Targeting Therapeutics Market, 2021-2035.” The report features
Roots Analysis is pleased to announce the publication of its recent study, titled, “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution of these self-injection devices over
Roots Analysis has announced the addition of the “Cell Therapy Consumables Market” report to its list of offerings. Currently, more than 800 IND applications have been filed for cell therapies, while close to 10 cell-based / gene therapies are likely to receive approval in 2021 across the world. This has prompted several drug developers to
Roots Analysis has announced the addition of “Protein Engineering Market” report to its list of offerings Owing to the various benefits offered by protein therapeutics this domain has gained significant traction from the medical community. Players engaged in the development of protein therapeutics have demonstrated a preference to continue relying on protein design and
The protein design and engineering services market Read More »
During our study, we were able to identify close to 500 players that are engaged in offering pharmaceutical contract manufacturing services. It is worth mentioning, most of the players (174) engaged in this domain offer contract manufacturing services for FDF / fill-finish operations, followed by those offering services for both API and FDF / fill-finish
PHARMACEUTICAL CONTRACT MANUFACTURING – CURRENT MARKET LANDSCAPE Read More »
Roots Analysis has announced the addition of “Alzheimer’s Disease Market (2nd Edition), 2021-2031” report to its list of offerings. Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and non-industry players are presently engaged in developing various types of disease modifying interventions and drug /
Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market” report to its list of offerings. Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in the formation of heme (an essential part of hemoglobin that helps carry oxygen in blood). Any anomaly caused by
The porphyria therapies market is projected to grow at an annualized rate of 10.97% Read More »
